S
ELV icon

SignatureFD’s Elevance Health ELV Stock Holding History

SignatureFD’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$620K Sell
2,118
-105
-5% -$34.5K 0.01% 535
2025
Q4 		$779K Sell
2,223
-74
-3% -$25K 0.01% 446
2025
Q3 		$742K Sell
2,297
-150
-6% -$46.7K 0.01% 460
2025
Q2 		$952K Sell
2,447
-479
-16% -$193K 0.02% 365
2025
Q1 		$1.27M Buy
2,926
+581
+25% +$233K 0.02% 277
2024
Q4 		$865K Sell
2,345
-2,109
-47% -$883K 0.02% 372
2024
Q3 		$2.32M Sell
4,454
-165
-4% -$88.1K 0.04% 153
2024
Q2 		$2.5M Buy
4,619
+351
+8% +$186K 0.05% 134
2024
Q1 		$2.21M Buy
4,268
+235
+6% +$117K 0.05% 147
2023
Q4 		$1.9M Sell
4,033
-62
-2% -$28.7K 0.04% 163
2023
Q3 		$1.78M Buy
4,095
+451
+12% +$205K 0.05% 148
2023
Q2 		$1.62M Buy
3,644
+447
+14% +$206K 0.04% 159
2023
Q1 		$1.47M Sell
3,197
-386
-11% -$184K 0.04% 164
2022
Q4 		$1.84M Buy
3,583
+405
+13% +$206K 0.05% 122
2022
Q3 		$1.44M Buy
3,178
+19
+0.6% +$9.09K 0.05% 135
2022
Q2 		$1.52M Sell
3,159
-68
-2% -$33.6K 0.05% 129
2022
Q1 		$1.58M Buy
3,227
+384
+14% +$176K 0.05% 147
2021
Q4 		$1.32M Buy
2,843
+88
+3% +$37K 0.04% 164
2021
Q3 		$1.03M Sell
2,755
-15
-0.5% -$5.7K 0.04% 195
2021
Q2 		$1.06M Sell
2,770
-271
-9% -$104K 0.04% 184
2021
Q1 		$1.09M Sell
3,041
-34
-1% -$10.9K 0.05% 146
2020
Q4 		$987K Buy
3,075
+147
+5% +$45.1K 0.05% 140
2020
Q3 		$786K Sell
2,928
-123
-4% -$33.1K 0.04% 162
2020
Q2 		$802K Sell
3,051
-366
-11% -$97.6K 0.05% 146
2020
Q1 		$776K Buy
3,417
+145
+4% +$39.5K 0.07% 129
2019
Q4 		$988K Buy
3,272
+119
+4% +$32.7K 0.07% 118
2019
Q3 		$757K Buy
3,153
+7
+0.2% +$1.92K 0.06% 129
2019
Q2 		$888K Buy
3,146
+86
+3% +$23.5K 0.08% 103
2019
Q1 		$878K Buy
3,060
+13
+0.4% +$3.76K 0.07% 102
2018
Q4 		$800K Buy
3,047
+287
+10% +$78.9K 0.07% 105
2018
Q3 		$756K Buy
2,760
+220
+9% +$57.1K 0.08% 131
2018
Q2 		$605K Buy
2,540
+37
+1% +$8.57K 0.07% 143
2018
Q1 		$550K Buy
2,503
+688
+38% +$162K 0.06% 131
2017
Q4 		$408K Buy
1,815
+97
+6% +$20.7K 0.05% 178
2017
Q3 		$326K Buy
1,718
+67
+4% +$12.8K 0.04% 191
2017
Q2 		$311K Buy
1,651
+127
+8% +$22.8K 0.05% 179
2017
Q1 		$252K Buy
+1,524
New +$242K 0.04% 221
2016
Q4 		– Sell
-1,024
Closed -$128K – 525
2016
Q3 		$128K Buy
1,024
+566
+124% +$73.1K 0.02% 303
2016
Q2 		$60K Sell
458
-55
-11% -$7.53K 0.01% 423
2016
Q1 		$71K Sell
513
-6
-1% -$802 0.01% 356
2015
Q4 		$72K Buy
519
+46
+10% +$6.34K 0.01% 297
2015
Q3 		$66K Buy
473
+79
+20% +$11.9K 0.02% 302
2015
Q2 		$65K Buy
394
+11
+3% +$1.76K 0.01% 294
2015
Q1 		$59K Buy
383
+4
+1% +$570 0.01% 292
2014
Q4 		$48K Sell
379
-387
-51% -$47.8K 0.01% 303
2014
Q3 		$92K Hold
766
– – 0.03% 181
2014
Q2 		$82K Sell
766
-194
-20% -$20K 0.03% 198
2014
Q1 		$96K Hold
960
– – 0.04% 123
2013
Q4 		$89K Buy
960
+134
+16% +$11.9K 0.03% 152
2013
Q3 		$69K Hold
826
– – 0.03% 167
2013
Q2 		$68K Buy
+826
New +$61.8K 0.04% 144

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

SignatureFD's ELV Position: Q1 2026 in Review

SignatureFD reduced its Elevance Health (ELV) stake by 4.7% in Q1 2026, selling an estimated $34.5K and leaving 2,118 shares worth $620K. The position accounts for 0.01% of the portfolio, ranked #535.

SignatureFD first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.5M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • SignatureFD held 2,118 shares of Elevance Health worth $620K as of Q1 2026.
  • SignatureFD sold 105 Elevance Health shares in Q1 2026, an estimated $34.5K.
  • Elevance Health made up 0.01% of SignatureFD's portfolio in Q1 2026, its #535 holding.
  • SignatureFD first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • SignatureFD's Elevance Health position peaked at $2.5M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.